Neoprobe Corporation (OTC BB: NEOP) has focused their efforts on developing and commercializing novel biomedical products that address the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. The company’s main area of dedication is on improving cancer surgery outcomes by utilizing their market-leading gamma detection devices in conjunction with radiopharmaceutical agents.
- 18 years ago
QualityStocks
Neoprobe Corporation (OTC BB: NGNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Numa Numa Resources Inc. Eyes Mining Opportunities as Bougainville Charts Its Future
Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources is supporting…
-
QualityStocksNewsBreaks – Market Street Capital Inc. Highlights Importance of Exit Readiness for Founders
Market Street Capital emphasizes that founders of privately held, middle-market businesses should begin preparing for an…
-
From Tokenization to Production: MindWave Innovations Inc. (NYSE American: APUS) Positions MindChain for the Next Phase of Real-World Assets
Real-world asset activity is moving beyond proof-of-concept deployments, with tokenized funds, Treasuries, private credit and…